Literature DB >> 18638835

Anti-Yo positive paraneoplastic cerebellar degeneration: a report of three cases and review of the literature.

T J O'Brien1, B Pasaliaris, A D'Apice, E Byrne.   

Abstract

Anti-Yo is an anti-Purkiney cell cytoplasmic antibody found in approximately 50% of patients with parancoplastic cerebellar degeneration (PCD). We report three patients with anti-Yo positive PCD (one ovarian carcinoma and two poorly differentiated adenocarcinomas consistent with breast origin). Two were treated with chemotherapy and plasmapheresis but died within months of the diagnosis from progressive neurological disease. The other was given gamma-globulin and has remained table at 6 months follow up. Anti-Yo antibodies are highly specific with almost all patients having breast or gynaecological malignanies. Commonly the tumour is of small volume and asymptomatic. Attempts at treatment are usually unsuccessful but there are a number of reports of stabilisation or improvement when treatment is begun before the development of severe neurological disability. The detection of anti-Yo antibodies is very useful for the diagnosis of PCD allowing early tumour detection and prompt institution of treatment.

Entities:  

Year:  1995        PMID: 18638835     DOI: 10.1016/0967-5868(95)90052-7

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


  9 in total

1.  Paraneoplastic cerebellar degeneration associated with serous adenocarcinoma of the ovary.

Authors:  Duaa B Saeed; Limci Gupta
Journal:  BMJ Case Rep       Date:  2014-11-28

Review 2.  Anti-Yo antibody-mediated paraneoplastic cerebellar degeneration associated with cognitive affective syndrome in a patient with breast cancer: a case report and literature review.

Authors:  M Le May; S Dent
Journal:  Curr Oncol       Date:  2018-12-01       Impact factor: 3.677

3.  Paraneoplastic Cerebellar Degeneration: The Importance of Including CDR2L as a Diagnostic Marker.

Authors:  Ida Herdlevær; Mette Haugen; Kibret Mazengia; Cecilie Totland; Christian Vedeler
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2021-02-02

Review 4.  Paraneoplastic cerebellar degeneration in platinum-responsive endometrial cancer: A case report and review of literature.

Authors:  Michalis Liontos; Oraianthi Fiste; Danai Drakopoulou; Nikolaos Thomakos; Kalliroi Goula; Flora Zagouri; Maria Anagnostouli; Meletios-Athanasios Dimopoulos
Journal:  Gynecol Oncol Rep       Date:  2021-06-29

5.  Anti-yo associated paraneoplastic cerebellar degeneration in a man with large cell cancer of the lung.

Authors:  Linda Hasadsri; James Lee; Bonnie H Wang; Lalitha Yekkirala; Mingtao Wang
Journal:  Case Rep Neurol Med       Date:  2013-09-19

Review 6.  Paraneoplastic cerebellar degeneration with anti-Yo antibodies - a review.

Authors:  Anand Venkatraman; Puneet Opal
Journal:  Ann Clin Transl Neurol       Date:  2016-06-30       Impact factor: 4.511

7.  High-resolution epitope mapping of anti-Hu and anti-Yo autoimmunity by programmable phage display.

Authors:  Brian O'Donovan; Caleigh Mandel-Brehm; Sara E Vazquez; Jamin Liu; Audrey V Parent; Mark S Anderson; Travis Kassimatis; Anastasia Zekeridou; Stephen L Hauser; Sean J Pittock; Eric Chow; Michael R Wilson; Joseph L DeRisi
Journal:  Brain Commun       Date:  2020-08-03

8.  Treatment of paraneoplastic cerebellar degeneration.

Authors:  John E Greenlee
Journal:  Curr Treat Options Neurol       Date:  2013-04       Impact factor: 3.598

9.  Combined Cerebellar and Spinal Cord Deficits Caused by an Underlying Gynecologic Malignancy.

Authors:  Tamer Othman; Moshe-Samuel Hendizadeh; Ritika Vankina; Susan Park; Phyllis Kim
Journal:  Case Rep Oncol Med       Date:  2020-01-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.